A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (The VIP-U Trial)
Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.07.679
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Elsevier BV